Frontlight ResearchEarly access
Trial site
Malteser Norddeutschland gGmbH
- 10running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia4 trials
- Lung cancer3 trials
- Multiple myeloma3 trials
- Hodgkin lymphoma2 trials
- Myelodysplastic syndromes2 trials
- Colorectal cancer1 trial
- Phase
- Phase 311 trials
- Phase 22 trials
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Completed3 trials
- Lead sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland3 trials
- University Of Cologne2 trials
- AIO-Studien-gGmbH1 trial
- AstraZeneca1 trial
- Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Lung cancer2 recruiting
- Hodgkin lymphoma1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026